Invention Grant
- Patent Title: Therapeutic agents
- Patent Title (中): 治疗剂
-
Application No.: US11915643Application Date: 2006-10-05
-
Publication No.: US07875626B2Publication Date: 2011-01-25
- Inventor: Leifeng Cheng
- Applicant: Leifeng Cheng
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Morgan Lewis & Bockius LLP
- International Application: PCT/GB2006/003695 WO 20061005
- International Announcement: WO2007/039740 WO 20070412
- Main IPC: C07D471/02
- IPC: C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02 ; A01N43/42 ; A61K31/44
Abstract:
The present invention relates to 4,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one and 4,5-dihydropyrrolo[3,2-c]pyridin-4-one compounds of formula (I) and processes for preparing such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods for their therapeutic use and to pharmaceutical compositions containing them.
Public/Granted literature
- US20080312269A1 Therapeutic Agents Public/Granted day:2008-12-18
Information query
